跳至主要内容
临床试验/NCT01819038
NCT01819038已完成不适用

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
mortality rate

研究概览

简要总结

This research project is a prospective study to compare mortality between early renal replacement therapy (RRT) and late renal replacement therapy by using plasma neutrophil gelatinase associated lipocalin (pNGAL) as a tool in decision- making.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The patient must have given his/her informed and signed consent
  • •patients with acute kidney injury in the intensive care ward.

排除标准

  • •The patient refuses to sign the consent
  • •The patient is pregnant, parturient, or breastfeeding
  • •End stage renal disease
  • •Chronic renal failure
  • •previous kidney transplant

研究组 & 干预措施

High NGAL and early RRT

Experimental

NGAL level > 400 ng/ml and start continuous renal replacement therapy early

干预措施: continuous renal replacement therapy (Procedure)

High NGAL and late RRT

Experimental

NGAL > 400 ng/ml and start continuous renal replacement therapy late

干预措施: continuous renal replacement therapy (Procedure)

Low NGAL

Active Comparator

NGAL < 400 ng/ml and starting continuous renal replacement therapy follow with absolute indication

干预措施: continuous renal replacement therapy (Procedure)

结局指标

主要结局

mortality rate

时间窗: 28 day

次要结局

  • ventilator free-days(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nattachai Srisawat ,M.D.

Principle Investigator

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验